KentCardio

10/02/2026

Kidney disease is becoming more common in the UK, often developing quietly with few warning signs until it’s advanced. Factors like high blood pressure, diabetes, obesity, and chronic inflammation all increase the risk – and most people don’t realise their kidneys may be under strain until significant damage has occurred.

In our latest article, we explain how understanding your individual risk and using advanced screening tools can help detect early signs of kidney dysfunction. Combining traditional clinical measures with deeper metabolic and functional assessments gives a more complete picture of organ health.

Early detection and targeted intervention can support better long‑term outcomes. Read the full article here - https://kentcardio.com/latest-news/kidney-disease-is-rising-understanding-your-risk/

04/02/2026

High blood pressure is often called the 'silent killer' because it usually has no symptoms – yet it remains one of the biggest preventable causes of heart attack, stroke, kidney disease and early death.

Recent data shows that many adults in the UK don’t know their blood pressure numbers or how often they should be checked.

In our latest article, we explain why regular monitoring is so important and how early detection offers the best chance to reduce long-term risk. Driving deeper than a single reading, advanced assessments can reveal patterns and trends that help guide personalised prevention and treatment strategies.

Read the full article here > https://kentcardio.com/latest-news/blood-pressure-monitoring-awareness/

19/01/2026

Emerging research now shows that profiling from simple pinprick blood samples can identify early biological signals associated with conditions like diabetes, heart disease, dementia, and cancer long before symptoms appear.

In our latest news article, we explore how the systems biology and functional medicine methods used by Dr Konrad Grosser, in a similar way to the blood tests, shifts the focus from reactive care to proactive prevention. Advanced testing can reveal hidden stress on metabolism, inflammation, immunity, and cellular function, helping patients take meaningful action years earlier.

Read the full article here - https://kentcardio.com/latest-news/pinprick-blood-tests-that-predict-disease-years-before-symptoms/

15/01/2026

King Charles’ recent public message about his cancer journey and the importance of early detection prompted thousands of people visited Cancer Research UK’s new Screening Checker tool to find out which screening tests apply to them.

In our latest article, we explore how this surge in interest highlights the value of early screening, advanced diagnostics, and proactive health monitoring. Waiting for symptoms can mean missed opportunities for early intervention – but combining standard programmes with functional, personalised testing can help identify hidden risk factors sooner.

Take a look at the article here > https://kentcardio.com/latest-news/royal-engagement-drives-cancer-screening-uptake-across-the-uk/

18/12/2025

A long-term Finnish study has found that risky behaviours such as smoking, heavy alcohol consumption and physical inactivity begin to negatively affect both physical and mental health as early as age 36.

In our latest article, we explore how lifestyle choices can contribute to long-term health issues, including increased risk of chronic disease and accelerated biological aging. The good news is that making changes early, and even in midlife, can still significantly improve your health trajectory.

Learn how personalised screening and functional medicine strategies can help you identify hidden risks and support a healthier future.

https://kentcardio.com/latest-news/how-your-party-lifestyle-catches-up-with-you/

17/12/2025

New technology may change how we think about heart and vascular health. A recent study shows that artificial intelligence (AI) can analyse signals from wearable devices to estimate vascular age – how old your blood vessels appear compared with your actual age. Higher vascular age was linked with significantly greater risk of heart attacks, stroke, diabetes and other cardiovascular events.

In our latest article, we explore how this new technology aligns supports functional medicine by identifying hidden disease long before symptoms develop so you can take meaningful action early.

Read the full article: https://kentcardio.com/latest-news/ai-vascular-age-from-wearables-predicts-disease-risk/

11/12/2025

Recent research suggests that a fixed-dose combination 'polypill', combining blood pressure and cholesterol medications, can lower the risk of heart attack and stroke. In large trials, polypills reduced cardiovascular risk by around 21–31% compared with placebo.

While this strategy offers promise in simplifying prevention and improving adherence, there’s ongoing debate over whether a broad approach is appropriate compared with individualised risk assessment.

In his latest article, Dr Konrad Grosser explores the limitations of the polypill in isolation and highlights how functional testing, systems biology, and targeted intervention can reveal hidden risk factors far earlier than traditional models alone.

Learn more in the latest news article > https://kentcardio.com/latest-news/individualised-care-vs-the-polypill-debate/

11/12/2025

Intermittent fasting is usually associated with weight management, but emerging research suggests that it could also benefit brain health and cognitive function. Studies show that fasting patterns may improve insulin sensitivity, support metabolic shifts that reduce inflammation and oxidative stress, and enhance memory and executive function compared with standard healthy diets. In some cases, intermittent fasting has been linked with improved markers of brain aging and better metabolic health in older adults.

In our latest article, Dr Konrad Grosser explores how intermittent fasting might influence biological aging and cognitive performance. Take a look here > https://kentcardio.com/latest-news/intermittent-fasting-and-the-cognitive-benefits-for-your-brain/

23/10/2025

Diagnoses of type 2 diabetes in people under 40 have surged by 40% in recent years.

In the latest blog, we look at how insulin resistance and metabolic dysfunction often begin years before diagnosis occurs. We explore how advanced testing, such as insulin resistance assessments, mitochondrial function, and biological age screening, can identify risk early and pave the way to real prevention.

Discover why early intervention matters and how a targeted, functional-medicine approach can help >

If you're concerned about blood sugar, insulin, or weight gain, book a consultation to explore your metabolic health and for treatments.

06/10/2025

In his new article, Dr Konrad Grosser explores a promising breakthrough treatment for adrenal-based hypertension, a subtype of high blood pressure rooted in hormonal and adrenal dysfunction, often overlooked in standard care.

By digging deeper into endocrine, metabolic, and hormonal systems, functional screening can reveal the hidden causes behind seemingly 'ordinary' hypertension. From there, a targeted, systems biology-based plan can address root drivers rather than just masking symptoms.

Read more: https://kentcardio.com/latest-news/a-breakthrough-treatment-for-adrenal-based-hypertension/

16/09/2025

With rising global temperatures, heatwaves aren’t just uncomfortable – they’re becoming a serious health risk, especially for older adults.

In our latest article, we explore how prolonged heat exposure impacts heart, metabolic, and immune systems – and why early detection through advanced screening is more important than ever. We share practical steps you can take now: optimising hydration, protecting sleep, checking blood pressure and heart health, supporting detox pathways, and using functional tests to uncover hidden risk.

Learn more here - https://kentcardio.com/latest-news/rising-heatwaves-and-impact-on-aging-populations/

03/09/2025

A recent groundbreaking study from the University of Surrey has uncovered specific genetic variants that elevate the risk of both type 2 diabetes and certain cancers – including breast, colorectal, and pancreatic cancer.

Through advanced functional screening, including TruAge and TruIntelli testing, combined with Dr Konrad Grosser’s systems biology approach, you can identify AND influence your true risk profile.

Discover practical strategies for early intervention:

• Targeted metabolic and hormone testing
• Nutritional optimisation and lifestyle support
• Personalised plans for cancer prevention and metabolic health

Read the full article here - https://kentcardio.com/latest-news/genetic-link-between-type-2-diabetes-and-cancer/